Effect modifiers in a randomized phase III trial of low-dose tamoxifen in breast preinvasive disease.Andrea De Censi, Bernardo Bonanni, Aliana Guerrieri‐Gonzaga et al.|Journal of Clinical Oncology|2019Cited by 3